Bioventus Inc.
Bioventus Inc. (BVS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BVS · as of Sep 30, 2025
Ownership Breakdown
137
Institutional Holders
▲ 1 vs Q2
$328.95M
Total Inst. Value
▲ $8.63M vs Q2
67.75M
Shares Outstanding
freeFloat 68.87%
49.17M
13F Shares Held
▲ 783,980 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BVS largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ESSEX WOODLANDS MANAGEMENT, INC. surgical & medical instruments & apparatus | 13.02M | 19.58% | 19.58% | $87.11B | Nov 12, 2025 | — held |
JUNIPER INVESTMENT COMPANY, LLC surgical & medical instruments & apparatus | 6.94M | 10.44% | 10.44% | $46.42B | Nov 14, 2025 | — held |
NANTAHALA CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 5.81M | 8.74% | 8.74% | $38.87B | Nov 14, 2025 | ▲ 529.8K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 3.07M | 4.61% | 4.61% | $20.53B | Nov 12, 2025 | ▼ 67.7K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 2.92M | 4.40% | 4.40% | $19.57B | Nov 7, 2025 | ▲ 122.7K |
ROYCE & ASSOCIATES LP surgical & medical instruments & apparatus | 1.26M | 1.90% | 1.90% | $8.45B | Nov 12, 2025 | ▲ 170.9K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.10M | 1.66% | 1.66% | $7.37B | Nov 12, 2025 | ▲ 45.9K |
AMERICAN CENTURY COMPANIES INC surgical & medical instruments & apparatus | 1.09M | 1.64% | 1.64% | $7.30B | Nov 12, 2025 | ▼ 33.0K |
KENT LAKE PR LLC surgical & medical instruments & apparatus | 1.00M | 1.50% | 1.50% | $6.69B | Nov 14, 2025 | ▲ 650.2K |
STATE STREET CORP surgical & medical instruments & apparatus | 876.4K | 1.32% | 1.32% | $5.86B | Nov 14, 2025 | ▼ 7.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
24
Increased
+3.13M shares5
New Positions
first time holders17
Decreased
−1.26M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.87M
+3.13M / −1.26M
Net new holders
+12
5 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BVS insider trading · insider activity
Source: SEC Form 4
23
Buy transactions
16
Sell transactions
1.44
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bartholdson John A.
| Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
SUTTER MARTIN P
| Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
STALNECKER SUSAN M director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
NOHRA GUY P director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
NEELS GUIDO J director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
McMurry-Heath Michelle director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
Ladone Mary Kay director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bioventus Inc. (BVS) is primarily owned by institutional investors, who hold approximately 72.6% of total shares outstanding. Company insiders own approximately 31.13%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Bioventus Inc. is ESSEX WOODLANDS MANAGEMENT, INC., holding approximately 13.02 million shares — equal to 19.58% of outstanding shares — as of September 30, 2025.
A total of 137 institutional investors currently hold BVS stock, with a combined institutional value of approximately $328,946,539 as of the most recent 13F filing period.
Frequently asked questions
BVS ownershipBioventus Inc. (BVS) is primarily owned by institutional investors, who hold approximately 72.6% of shares. The largest shareholder is ESSEX WOODLANDS MANAGEMENT, INC. with a 19.58% stake. Company insiders hold 31.13%. Data sourced from SEC Form 13F as of September 30, 2025.